National Institute for Health and Care Excellence Backs Darzalex®▼ (daratumumab) in Combination with Velcade® (bortezomib), Thalidomide and Dexamethasone (DVTd) for Patients with Newly Diagnosed Multiple Myeloma High Wycombe, 22nd December 2021 – The Janssen Pharmaceutical Companies of Johnson &a.